027-潇湘夜雨2021-12-01 23:05
$BioLineRx(BLRX)$ 万春倒下,你应该雄起啊$万春医药(BYSI)$
今开:1.26 | 昨收:1.27 |
最高:1.3216 | 最低:1.25 |
涨停价: | 跌停价: |
总市值:60549875 |
027-潇湘夜雨2021-12-01 23:05
$BioLineRx(BLRX)$ 万春倒下,你应该雄起啊$万春医药(BYSI)$
BioLineRx(BLRX)2021-11-18 20:21
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003640 Act: 34 Size: 970 KB 网页链接
BioLineRx(BLRX)2021-11-04 22:21
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003387 Act: 34 Size: 173 KB 网页链接
Wisteria-2021-10-14 16:32
BLRX(BioLineRx Ltd) 是一家专注于肿瘤学的以色列临床阶段生物制药公司,其肿瘤学项目包括 Motaxafortide (BL-8040),这是用于治疗胰腺癌的治疗平台;AGI-134是一种用于多种实体瘤的免疫疗法。 昨天13-Oct-21,BioLineRx 宣布了一项将其 Motixafortide 作为潜在的干细胞动员护理标准的药物经济...
BioLineRx(BLRX)2021-10-28 05:12
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003281 Act: 34 Size: 152 KB 网页链接
027-潇湘夜雨2021-10-22 11:49
$BioLineRx(BLRX)$ 最近波动明显加大了,好事将近?
BioLineRx(BLRX)2021-10-13 20:42
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003161 Act: 34 Size: 48 KB 网页链接
BioLineRx(BLRX)2021-09-22 00:18
$BioLineRx(BLRX)$ CT ORDER Confidential treatment order Accession Number: 9999999997-21-004816 Act: 34 Size: 160 KB 网页链接
BioLineRx(BLRX)2021-09-04 04:36
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-002928 Act: 34 Size: 324 KB 网页链接
Linktu2021-07-03 03:57
$BioLineRx(BLRX)$ 希望被收购梦想成真
BioLineRx(BLRX)05-11 19:18
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-001863 Act: 34 Size: 918 KB 网页链接查看全文
BioLineRx(BLRX)03-16 19:33
$BioLineRx(BLRX)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-22-001134 Act: 34 Size: 12 MB 网页链接查看全文
BioLineRx(BLRX)03-16 19:18
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-001132 Act: 34 Size: 415 KB 网页链接查看全文
BioLineRx(BLRX)03-03 20:18
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000899 Act: 34 Size: 45 KB 网页链接查看全文
BioLineRx(BLRX)02-11 19:57
$BioLineRx(BLRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-22-006668 Act: 34 Size: 52 KB 网页链接查看全文
BioLineRx(BLRX)01-24 20:18
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000197 Act: 34 Size: 40 KB 网页链接查看全文
BioLineRx(BLRX)01-18 20:21
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000147 Act: 34 Size: 36 KB 网页链接查看全文
BioLineRx(BLRX)2021-12-17 20:18
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003882 Act: 34 Size: 39 KB 网页链接查看全文
BioLineRx(BLRX)2021-12-15 20:33
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003868 Act: 34 Size: 44 KB 网页链接查看全文
BioLineRx(BLRX)2021-12-04 05:36
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003777 Act: 34 Size: 12 KB 网页链接查看全文
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-001863 Act: 34 Size: 918 KB 网页链接
$BioLineRx(BLRX)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-22-001134 Act: 34 Size: 12 MB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-001132 Act: 34 Size: 415 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000899 Act: 34 Size: 45 KB 网页链接
$BioLineRx(BLRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-22-006668 Act: 34 Size: 52 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000197 Act: 34 Size: 40 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-22-000147 Act: 34 Size: 36 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003882 Act: 34 Size: 39 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003868 Act: 34 Size: 44 KB 网页链接
$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-21-003777 Act: 34 Size: 12 KB 网页链接